| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 658.03M | 648.08M | 642.66M | 625.48M | 565.39M |
| Gross Profit | 335.92M | 392.26M | 377.96M | 368.70M | 370.13M |
| EBITDA | 384.81M | 396.49M | 393.12M | 324.39M | 440.83M |
| Net Income | 338.05M | 330.22M | 307.10M | 235.51M | 354.48M |
Balance Sheet | |||||
| Total Assets | 5.13B | 4.85B | 4.48B | 4.19B | 3.96B |
| Cash, Cash Equivalents and Short-Term Investments | 702.17M | 689.88M | 524.64M | 322.07M | 475.89M |
| Total Debt | 540.01M | 601.85M | 546.25M | 496.12M | 456.73M |
| Total Liabilities | 1.08B | 1.13B | 1.01B | 957.52M | 896.87M |
| Stockholders Equity | 4.05B | 3.72B | 3.46B | 3.23B | 3.07B |
Cash Flow | |||||
| Free Cash Flow | 319.92M | 452.35M | 364.25M | 383.69M | 413.74M |
| Operating Cash Flow | 361.92M | 480.43M | 391.37M | 428.95M | 453.77M |
| Investing Cash Flow | -94.97M | -531.75M | -281.36M | -467.96M | -844.45M |
| Financing Cash Flow | -48.73M | -51.56M | -57.48M | -140.88M | 28.36M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$3.34B | 5.81 | 15.20% | ― | 7.50% | 5.93% | |
75 Outperform | HK$784.19M | 3.04 | 9.79% | 6.83% | 3.55% | 8.38% | |
63 Neutral | HK$715.82M | 2.52 | 8.40% | 11.09% | 1.47% | 1.93% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
42 Neutral | HK$506.13M | -0.23 | -15.64% | 5.30% | -15.33% | -64500.00% |